Thryv Therapeutics jobs and careers

thryvtrx.com LinkedIn @LqtTherapeutics

About Thryv Therapeutics

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventriculararrhythmias. Click below to learn more about our programs.

Biotechnology Therapeutics

Employees: 1 to 10

Leadership

The top of Thryv Therapeutics's org chart, with how many people report into each leader.

PT

Paul F. Truex

Chairman & CEO

13 reports

PS

Philip Sager

Chief Medical Officer

6 reports

DO

Debra Odink

President & Chief Development Officer

4 reports

AM

Aidan McNeil

Associate General Counsel & VP, Administration

Board

FA

Frédéric Lemaître Auger

Board Observer

MA

Michael J Ackerman

Scientific Advisor

DH

Daniel Hétu

Director

AW

Arthur A.m. Wilde

Scientific Advisor

SN

Stanley Nattel

Scientific Advisor

RB

Robert Booth

Director

Jobs at Thryv Therapeutics

No open positions right now. Explore more companies on TheJobsMap.